RhumbLine Advisers’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $15.4K | Sell |
|
|||||
|
2024
Q4 | $186K | Buy |
|
|||||
|
2024
Q3 | $35.9K | Sell |
|
|||||
|
2024
Q2 | $194K | Buy |
|
|||||
|
2024
Q1 | $131K | Sell |
|
|||||
|
2023
Q4 | $164K | Sell |
|
|||||
|
2023
Q3 | $91K | Buy |
|
|||||
|
2023
Q2 | $118K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $104K | Sell |
|
|||||
|
2021
Q4 | $122K | Buy |
|
|||||
|
2021
Q3 | $162K | Buy |
|
|||||
|
2021
Q2 | $145K | Sell |
|
|||||
|
2021
Q1 | $204K | Sell |
|
|||||
|
2020
Q4 | $162K | Buy |
|
|||||
|
2020
Q3 | $102K | Sell |
|
|||||
|
2020
Q2 | $169K | Sell |
|
|||||
|
2020
Q1 | $189K | Buy |
|
|||||
|
2019
Q4 | $274K | Buy |
|
|||||
|
2019
Q3 | $250K | Buy |
|
|||||
|
2019
Q2 | $186K | Buy |
|
|||||
|
2019
Q1 | $111K | Buy |
|